By Editor , 27 October 2026
Lead Image
Duchenne Gene Therapy SGT-003 Has Now Dosed 53 Boys in Trial

Global – October 27, 2026 -- Fifty-three boys with Duchenne muscular dystrophy have now received the investigational gene therapy SGT-003, and a Phase 3 trial is already enrolling patients in Australia and Canada. Solid Biosciences shared the update in a letter to the Duchenne community as the annual Parent Project Muscular Dystrophy (PPMD) conference got under way.

By Editor , 27 October 2026
Lead Image
Duchenne Gene Therapy SGT-003: 15 Patients Dosed So Far

United States – October 27, 2026 -- Fifteen people with Duchenne muscular dystrophy had received the investigational gene therapy SGT-003 in the INSPIRE DUCHENNE clinical study as of August 12, 2025, according to developer Solid Biosciences.

Ten trial sites span four countries

The multi-center, open-label trial now runs 10 active clinical sites in the United States, Canada, Italy, and the United Kingdom. More sites are expected to open later this year.

By Editor , 25 October 2026

Canada – October 24, 2026 -- A set of Canadian banking case studies shows how mortgage insurance premiums, 0% balance transfer offers and card disputes can raise costs for ordinary customers.

Homebuyers and balance transfers face extra costs

Mr. and Ms. D put down less than 20% of the purchase price, so Canadian mortgage rules required an insured mortgage. The bank arranged the insurance. Their case centres on late disclosure of a higher premium, which added costs for the couple and ended in a low settlement.

By Editor , 6 October 2026
Lead Image
Angelcare Launches Hygenie, a Discreet Home Disposal System for Adult Incontinence Care

Canada – October 06, 2026 -- Angelcare Group has launched Hygenie, a new disposal system for adult incontinence products designed to blend into home decor while locking in odor. The pail system, which ships with 24 refill bags, is now available on Amazon US and Target online for $84.99 USD.

An odor-locking clamp seals waste instantly

Hygenie uses a clamp system engineered in Canada that seals immediately after each use, the company says, aiming to control odor without interrupting daily routines for users or caregivers.

By Editor , 15 September 2026
Lead Image
Great Rail Journeys Launches Landmark Collection of Luxury Train Tours

Chicago – September 15, 2026 -- Great Rail Journeys, formerly known as Vacations By Rail, has launched a new Landmark Collection of premium escorted vacations, now open for booking through 2027.

The portfolio spans Europe, Canada, Africa and the United Kingdom, with itineraries running 7 to 17 days and combining iconic train routes, luxury hotels and small-group touring.

By Editor , 1 September 2026
Lead Image
Inturai Ventures Raises $940,999 in First Round of Private Placement

Vancouver, BC -- September 01, 2026 -- Inturai Ventures Corp., the company behind AI-driven technology for healthcare, military, and smart home systems, closed the first tranche of its private placement on August 28, 2026, raising gross proceeds of $940,999.65. The Vancouver-based firm, listed as CSE: URAI, OTC: URAIF, and FSE: 3QG0, issued 6,273,331 Units at $0.15 each to investors. The company said it plans to close the remaining portion of the offering in one or more additional tranches over the coming weeks.

By Editor , 1 September 2026
Lead Image
Evan Kung Breaks Smallmouth Record for First Bassmaster Elite Win

CLAYTON, N.Y. -- September 01, 2026 -- Evan Kung, a Canadian pro fighting to keep his roster spot on the Bassmaster Elite Series, won the 2026 Lowrance Bassmaster Elite at St. Lawrence River on Aug. 30 with a four-day total of 109 pounds, 9 ounces. The catch set a new Bassmaster record for the heaviest winning weight made up entirely of smallmouth bass. The win also locked in Kung's berth at the 2027 Bass Pro Shops Bassmaster Classic presented by Under Armour, set for next March.

By Editor , 31 August 2026
Lead Image
Pharmacists May Soon Handle More of Your Primary Care

MONTRÉAL -- August 30, 2026 -- Patients who wait weeks for a doctor's appointment to manage a chronic condition like diabetes or high blood pressure could increasingly turn to a pharmacist instead, under integration plans discussed by global pharmacy leaders gathered in Montréal on August 28, 2026. Health regulators, academics and pharmacy association heads from the United States, Canada and other countries met for the International Forum on Primary Health Care to pinpoint what's holding pharmacists back from taking on bigger clinical roles.